Your browser doesn't support javascript.
Myocarditis following rAd26 and rAd5 vector-based COVID-19 vaccine: case report.
Naghashzadeh, Farah; Shafaghi, Shadi; Dorudinia, Atosa; Naji, Seyed Alireza; Marjani, Majid; Amin, Ahmad; Mohamadifar, Arezoo; Noorali, Sima; Kashani, Babak Sharif.
  • Naghashzadeh F; Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shafaghi S; Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Dorudinia A; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Naji SA; Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Dr. Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Marjani M; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Amin A; Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Mohamadifar A; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Noorali S; Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Kashani BS; Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ESC Heart Fail ; 9(2): 1483-1486, 2022 04.
Article in English | MEDLINE | ID: covidwho-1664406
ABSTRACT
SARS-CoV-2 vaccines provide a safe solution with a major impact on reducing the spread of the virus and mild side effects. Research has shown rare cases of myocarditis after mRNA vaccines. This study presents a 29-year-old male with chest pain after 48 h of receiving rAd26 and rAd5 vector-based COVID-19 vaccine (Sputnik V vaccine). The electrocardiogram revealed ST-segment elevation. Also, the laboratory screening was remarkable for elevated cardiac Troponin-I level, and leukocytosis; and echocardiography depicted severe left ventricular systolic dysfunction. Overall, endomyocardial biopsy proved lymphocytic myocarditis such that the patient was successfully treated with immunosuppressive and guideline-directed medical treatment.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Case report / Diagnostic study Topics: Vaccines Limits: Adult / Humans / Male Language: English Journal: ESC Heart Fail Year: 2022 Document Type: Article Affiliation country: Ehf2.13821

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Case report / Diagnostic study Topics: Vaccines Limits: Adult / Humans / Male Language: English Journal: ESC Heart Fail Year: 2022 Document Type: Article Affiliation country: Ehf2.13821